Equities Research Analysts’ Price Target Changes for September 15th (ABOS, AU, AXR, AZN, BARC, BBNX, BLKB, BNTC, BWIN, CAKE)
Equities Research Analysts’ price target changes for Tuesday, September 15th: Acumen Pharmaceuticals (NASDAQ:ABOS) had its price target increased by Citigroup Inc. from $4.00 to $5.00. Citigroup Inc. currently has a buy rating on the stock. AngloGold Ashanti (NYSE:AU) had its target price increased by JPMorgan Chase & Co. from $134.00 to $140.00. They currently have […]
15 Sep 17:44 · The Markets Daily